- Exchanges
- BSE, NSE
- Industry
- Specialty Chemicals
- Issue
- Book building
Omkar Speciality Chemicals IPO
₹46.45
−52.60% on listing
Listing-day close · NSE · 10 Feb 2011 · issue price ₹98
Omkar Speciality Chemicals’ ₹79.38 crore IPO was priced at ₹98 a share. It listed on the NSE on 10 Feb 2011 and closed its first day at ₹46.45, down 52.60% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Listing
Issue details
- Issue size
- ₹79.38 Cr
- Fresh issue
- ₹79.38 Cr
- Offer for sale
- —
- Lot size
- 60 shares
- Minimum investment
- ₹5,880
- Face value
- ₹10
- Registrar
- Bigshare Services
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 4.42× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹192 Cr
- ROCE
- 28.20%
- Promoter holding
- 100.00% → 58.73%
From the offer documents.
Listing
- Listing date
- 10 Feb 2011
- Issue price
- ₹98
- Open
- ₹92.00
- High
- ₹101.00
- Low
- ₹42.05
- Close
- ₹46.45
Listing day on the NSE. The close was −52.60% on the issue price.
FAQs
When did the Omkar Speciality Chemicals IPO open and close?
It opened on 24 Jan 2011 and closed on 27 Jan 2011.
What was the Omkar Speciality Chemicals IPO price?
The price band was ₹95–98 a share. The final issue price was ₹98.
What is the lot size and minimum investment?
One lot is 60 shares, ₹5,880 at ₹98 a share. Retail investors apply in whole lots.
How much did Omkar Speciality Chemicals raise?
₹79.38 crore: ₹79.38 crore of new shares.
How many times was the Omkar Speciality Chemicals IPO subscribed?
4.42 times overall.
How did Omkar Speciality Chemicals list?
It listed on the NSE on 10 Feb 2011 at ₹92.00 and closed the day at ₹46.45, down 52.60% on the ₹98 issue price.
Who is the registrar of the Omkar Speciality Chemicals IPO?
Bigshare Services handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app